Novel vaccine containing adjuvant capable of inducing mucosal immunity

Details for Australian Patent Application No. 2004263037 (hide)

Owner The Research Foundation for Microbial Diseases of Osaka University Japan as represented by The Director-General of National Institute of Infectious Diseases Toray Industries, Inc.

Inventors Tanimoto, Takefumi; Sata, Tetsutarou; Hasegawa, Hideki; Kurata, Takeshi; Tamura, Shin-Ichi; Moriyama, Masami

Agent Griffith Hack

Pub. Number AU-B-2004263037

PCT Pub. Number WO2005/014038

Priority 2003-291879 11.08.03 JP

Filing date 10 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 10 February 2011

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014038 Priority application(s): WO2005/014038

10 February 2011 Application Accepted

  Published as AU-B-2004263037

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263039-Aerosol for controlling insect pests

2004263036-Glycyrrhizin high-concentration preparation